IS

Ikbal Singh

Active Director Additional Director DIN 10925886
DIN 10925886 First appointment Jan 2025 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Ikbal Singh

Data last updated:

Ikbal Singh is an Additional Director at Manns Tbi Limited (since 2025). The company operates in Business Services.

DIN 10925886
Primary Designation Additional Director
Industry Business Services
First Appointment 23 Jan 2025
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Manns Tbi Limited U74999MH2022PLC390136
Additional Director23 Jan 20252022Active

Board colleagues of Ikbal Singh

NameDINCompanyDesignation
Arun Kumar Singh09034276Manns Tbi LimitedAdditional Director
Kamal Girdhar10849261Manns Tbi LimitedAdditional Director
Kartikey Keshri09730839Manns Tbi LimitedDirector

Directorship timeline

Open interactive timeline →
Manns Tbi Limited
Premium access

Shareholding and investment profile for Ikbal Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ikbal Singh

Ikbal Singh currently holds 1 directorship: Manns Tbi Limited (Additional Director, since 23 Jan 2025).

Ikbal Singh was first appointed on 23 Jan 2025 as Additional Director at Manns Tbi Limited.

The current boards of Ikbal Singh's companies include Arun Kumar Singh (Manns Tbi Limited), Kamal Girdhar (Manns Tbi Limited), Kartikey Keshri (Manns Tbi Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available